Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Completed Journey
Companies On The Road
Follow The Artist
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Completed Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
2023 Nice Insight Reports
Cell & Gene Therapy: 2023 Market Analysis, CDMO Pricing and Benchmarking
Monoclonal Antibody & Recombinant Protein: 2023 Market Analysis, CDMO Pricing and Benchmarking
mRNA Vaccines & Therapeutics: 2023 Market Analysis, CDMO Pricing and Benchmarking
Sterile Drug Product: 2023 Market Analysis, CDMO Pricing and Benchmarking
Active Pharmaceutical Ingredients: 2023 Market Analysis, CDMO Pricing and Benchmarking
Antibody Drug Conjugates: 2023 Market Analysis, CDMO Pricing and Benchmarking
Contract Research Organizations: 2023 Market Analysis, Pricing and Benchmarking
Oral Solid Dosage: 2023 Market Analysis, CDMO Pricing and Benchmarking
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Brammer Bio
21 Articles Available
Can't find what you're looking for? Try our
advanced search
.
Investment
Investing at the Intersection of Industrial Manufacturing and Healthcare
PAP-Q2-20-CL-025
Viral Vector Manufacturing
Accelerating The Development of Viral Vector Manufacturing Processes
PAP-Q2-2019-CL-009
Executive Q&A
Q&A: Building a Successful CDMO Brand
PAP-Q2-2019-CL-024
M&A
Brammer Bio Purchased by Thermo Fisher Scientific
PAO-M03-19-NI-032
Acquistion
Thermo Fisher Scientific to Acquire Brammer Bio, a Leader in Viral Vector Manufacturing
PR-M03-19-NI-078
QPCR
Digital Droplet PCR for Viral Vector Analysis
PAP-Q1-2019-CL-005
Facility
DPS Group Selected to Design Two cGMP Commercial Manufacturing Facilities for Brammer Bio
PR-M01-19-NI-036
Appointment
Brammer Bolsters Leadership Team and Announces Chief Quality Officer
PR-M01-19-NI-019
Viral Vector Manufacturing
From Proof of Concept to Commercialization
PAP-Q4-18-CL-003
Cell and Gene Therapy
Analytical Methodologies Utilized in Therapeutic Viral Vector Manufacturing
PAP-Q3-18-CL-001
Cell and Gene Therapy
Brammer Bio Announces Progress on $200 Million Program to Advance Gene Therapies
PR-M09-18-NI-096
Cell and Gene Therapy
Overcoming Raw Material and Supply Chain Challenges in Viral Vector Manufacturing
PAP-Q2-18-CL-011
Appointment
Brammer Bio Expands Leadership Team for Commercial Readiness
PR-M03-18-NI-080
Viral Vector
Ensuring Confidence in Viral Vector Manufacturing
PAP-Q1-18-CL-012
Cell and Gene Therapy
Brammer Bio Supports Rare Disease Day 2018
PR-M03-18-NI-006
Cell and Gene Therapy
Brammer Bio Completes Renovations at Manufacturing Site in Massachusetts
PAO-M12-17-NI-006
Bioprocessing
Brammer Bio Leverages Advanced Bioprocessing Technologies to Accelerate Capacity
PAO-M10-17-NI-002
Transient Transfection
Transient Transfection at a Large Scale for Flexibility in Clinical and Commercial Vector Manufacturing
PAP-Q3-17-CL-005
CDMO
Supporting the Tech Transfer Continuum for Cell & Gene Therapies
PAP-Q2-17-CL-003
Investing for Successful Advancement of Viral Vector Manufacturing
PAP-Q1-17-CL-007
Brammer Bio: Manufacturing Personalized
PAP-Q02-16-DL-001
